Avi Schroeder

Avi Schroeder

Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Technion - Israel Institute of Technology

Affiliated withTechnion - Israel Institute of Technology

Research Area

Biography

Avi Schroeder is an Associate Professor of Chemical Engineering at the Technion – Israel Institute of Technology where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (https://www.schroederlab.com/ ).

Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD jointly at the Hebrew and Ben Gurion Universities.

Avi is the recipient of more than 30 national and international awards, including named a KAVLI Fellow, the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Awards. Avi is the author of more than 50 research papers inventor of 19 patents and co-founder of several startup companies based on these discoveries.

Schroeder is a member of Israel Young National Academy of Sciences, and the President of the Israel Institute of Chemical Engineers.

JoVE Journal Publications

ArticleTotal : 1
Year
Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer
Publication title

Cited by 12

2020

Other Publications

Article
Year
Liposomes act as effective biolubricants for friction reduction in human synovial joints.

Langmuir : the ACS journal of surfaces and colloids| PubMed ID: 20014818

2010
2014
Small RNA combination therapy for lung cancer.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 25114235

2014
Microneedles for drug delivery via the gastrointestinal tract.

Journal of pharmaceutical sciences| PubMed ID: 25250829

2015
Ultrasound-mediated gastrointestinal drug delivery.

Science translational medicine| PubMed ID: 26491078

2015
2016
Autonomous bacterial nanoswimmers target cancer.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 27744036

2017
2016
2016
2017
Synthetic Cells Synthesize Therapeutic Proteins inside Tumors.

Advanced healthcare materials| PubMed ID: 29283226

2018
Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery.

International journal of biological macromolecules| PubMed ID: 29292143

2018
2018
2018
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 30615983

2019
Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31238049

2019
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.

Advanced materials (Deerfield Beach, Fla.)| PubMed ID: 31286573

2020
Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems.

Chemical engineering journal (Lausanne, Switzerland : 1996)| PubMed ID: 31384170

2018
Mucoadhesive Hybrid Polymer/Liposome Pastes Based on Modified Polysaccharides.

Journal of pharmaceutical sciences| PubMed ID: 31491439

2019
2019
2020